U.S. delays decision on HIV-prevention pill June 9, 2012 - 16:51 AMT PanARMENIAN.Net - Drug maker Gilead Sciences has said US health regulators have delayed a decision on whether to approve Truvada as the first pill that prevents HIV infection, Belfast Telegraph reported. Gilead Sciences said the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California company submitted additional materials to the agency earlier this month. In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV. The group's vote is non-binding, but the FDA often follows its advice. Gilead said it submitted updated details on its safety materials for patients and doctors using Truvada. The FDA typically extends its reviews after receiving such information.   Top stories Azerbaijani President Ilham Aliyev arrived in Moscow on April 22 to hold talks with Russian counterpart Vladimir Putin. Authorities said a total of 192 Azerbaijani troops were killed and 511 were wounded during Azerbaijan’s offensive. In 2023, the Azerbaijani government will increase the country’s defense budget by more than 1.1 billion manats ($650 million). The bill, published on Monday, is designed to "eliminate the shortcomings of an unreasonably broad interpretation of the key concept of "compatriot".   Partner news |  Latest news Ucom’s fixed network launches in Nor Hachn  City residents will be able to use fixed-line Internet, mobile communications and television in one package at more affordable prices.Armenia parliament to consider draft proposal on impeachment June 17 The Armenian Parliament will hold an extraordinary session on June 17 to consider a draft proposal on the resignation of the government.Armenia to send Deputy Foreign Minister to Berlin’s Ukraine Recovery Conference Georgia will attend the forum at the level of Prime Minister, Foreign Minister, while Azerbaijan will send their Foreign Minister.About 173 million drams and more than 30 beneficiary funds. "The Power of One Dram" is 4 years old In June 2020, the exclusive joint corporate social responsibility initiative of Idram and IDBank "The Power of One Dram" was launched. |
